Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Naunyn Schmiedebergs Arch Pharmacol. 2019 Mar;392(3):313-326. doi: 10.1007/s00210-018-1580-7. Epub 2018 Nov 28.
Sensory contact model (SCM) permits the evolution of diverse psychopathological states by the repeated antagonistic interactions between male mice. Biphenyl dimethyl dicarboxylate (DDB) is used as a hepatoprotective agent. The present work aimed to study the possible effects of DDB on social behavior developed by SCM by studying its effects on the transformation process to aggressive and submissive behaviors. Besides, measuring behavioral changes using the open field test (OFT) and the elevated plus maze test (EPM), neurochemical parameters [serotonin (5HT), norepqinephrine (NE), and dopamine(DA)], and immunological changes (total leucocyte count, differential leucocytic count, and evaluation of bone marrow lymphocytes count and viability assessment). Adult male Swiss mice were used; DDB was given in a dose of 100 mg/kg by oral gavage daily for 2 weeks from the fifth day to the last day of the SCM. The present study concluded that administration of DDB to the SCM involved animals was shown to be associated with significant positive impacts on the behavior of depressed partner in the SCM which were manifested by decreased latency and increased ambulation and rearing in OFT, increased number of entry in the open arm/total no of entries in EPM. This was associated with changes in brain levels of neurotransmitters which were manifested by increased NE and decreased DA, as well as the examined immunity related parameters which were manifested by increased total leucocyte count, bone marrow lymphocytes, and monocytes. So DDB can be used as a supportive antidepressant agent in patients with liver impairment and should be avoided in aggressive ones. However, more randomized controlled trials should be carried out to ascertain these effects.
感觉接触模型(SCM)允许通过雄性小鼠之间的反复拮抗相互作用来进化出不同的精神病理学状态。联苯二甲酸二甲酯(DDB)被用作一种保肝剂。本工作旨在通过研究 DDB 对攻击性和顺从性行为转化过程的影响,研究其对 SCM 发展的社会行为的可能影响。此外,使用旷场试验(OFT)和高架十字迷宫试验(EPM)测量行为变化,神经化学参数[血清素(5-HT)、去甲肾上腺素(NE)和多巴胺(DA)],以及免疫变化(总白细胞计数、白细胞分类计数以及骨髓淋巴细胞计数和活力评估)。使用成年雄性瑞士小鼠;DDB 通过口服灌胃每天给予 100mg/kg,从 SCM 的第 5 天到最后一天连续 2 周给药。本研究得出结论,向 SCM 中涉及的动物给予 DDB 显示与 SCM 中抑郁伴侣的行为有显著的积极影响有关,这表现为 OFT 中的潜伏期减少和活动度和站立增加,EPM 中进入开放臂的次数/总进入次数增加。这与脑内神经递质水平的变化有关,表现为 NE 增加和 DA 减少,以及检查的免疫相关参数的变化,表现为总白细胞计数、骨髓淋巴细胞和单核细胞增加。因此,DDB 可作为肝功能不全患者的辅助抗抑郁药使用,但应避免用于攻击性患者。然而,应该进行更多的随机对照试验来确定这些效果。